ClinicalTrials.gov record
Recruiting Phase 2 Interventional

Study of COYA 302 for the Treatment of ALS

ClinicalTrials.gov ID: NCT07161999

Public ClinicalTrials.gov record NCT07161999. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 8, 2026, 4:25 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Phase 2, Randomized, Double-Blind, Placebo-Controlled, Multi-Center, 24-Week Study With Additional 24-Week Blinded Active Extension to Evaluate the Safety and Efficacy of COYA 302 for the Treatment of Amyotrophic Lateral Sclerosis (ALS)

Study identification

NCT ID
NCT07161999
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 2
Lead sponsor
Coya Therapeutics
Industry
Enrollment
120 participants

Conditions and interventions

Interventions

  • COYA 302 Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 80 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 30, 2025
Primary completion
Dec 31, 2026
Completion
Jun 30, 2027
Last update posted
Apr 19, 2026

2025 – 2027

United States locations

U.S. sites
21
U.S. states
13
U.S. cities
20
Facility City State ZIP Site status
Barrow Neurological Institute Phoenix Arizona 85013 Recruiting
Cedars-Sinai Medical Center Los Angeles California 90048 Recruiting
California Pacific Medical Center San Francisco California 94110 Recruiting
Nova Southeastern University Davie Florida 33314 Recruiting
University of Florida Clinical and Translational Research Center Gainesville Florida 32610 Recruiting
University Of Miami Miami Florida 33136 Recruiting
University of South Florida Tampa Florida 33612 Recruiting
Emory University Atlanta Georgia 30322 Recruiting
Northwestern Chicago Illinois 60611 Recruiting
Johns Hopkins Baltimore Maryland 21287 Recruiting
Massachusetts General Hospital Boston Massachusetts 02114 Recruiting
University of Michigan Ann Arbor Michigan 48109 Recruiting
Washington University St Louis Missouri 63110 Recruiting
Neurology Associates, P.C. Somnos Clinical Research Lincoln Nebraska 68510 Active, not recruiting
Columbia University Medical Center ALS Center New York New York 10032 Recruiting
Thomas Jefferson University-Weinberg ALS Center Philadelphia Pennsylvania 19107 Recruiting
Temple Neurology Philadelphia Pennsylvania 19140 Recruiting
Austin Neuromuscular Center; National Neuromuscular Research Institute, PLLC Austin Texas 78759 Recruiting
Texas Neurology, PA Dallas Texas 75206 Recruiting
Houston Methodist Stanley H. Appel Department of Neurology Houston Texas 77030 Recruiting
The University of Texas Health Science Center San Antonio Texas 78229 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 4 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT07161999, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 19, 2026 · Synced May 8, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT07161999 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →